Home » Stocks » Co-Diagnostics

Co-Diagnostics, Inc. (CODX)

Stock Price: $14.23 USD 0.19 (1.35%)
Updated Oct 27, 2020 3:59 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 399.62M
Revenue (ttm) 25.74M
Net Income (ttm) 8.09M
Shares Out 28.08M
EPS (ttm) 0.35
PE Ratio 40.66
Forward PE 4.43
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Oct 27, 2020
Last Price $14.23
Previous Close $14.04
Change ($) 0.19
Change (%) 1.35%
Day's Open 13.61
Day's Range 13.10 - 14.38
Day's Volume 1,804,164
52-Week Range 0.85 - 30.99

More Stats

Market Cap 399.62M
Enterprise Value 381.07M
Earnings Date (est) Nov 11, 2020
Ex-Dividend Date n/a
Shares Outstanding 28.08M
Float 26.34M
EPS (basic) 0.22
EPS (diluted) 0.35
FCF / Share -0.13
Dividend n/a
Dividend Yield n/a
Earnings Yield 2.46%
FCF Yield n/a
Payout Ratio n/a
Shares Short 6.92M
Short Ratio 1.49
Short % of Float 26.27%
Beta -1.68
PE Ratio 40.66
Forward PE 4.43
P/FCF Ratio n/a
PS Ratio 15.53
PB Ratio 10.49
Revenue 25.74M
Operating Income 7.98M
Net Income 8.09M
Free Cash Flow -3.44M
Net Cash 18.55M
Net Cash / Share 0.66
Gross Margin 0.40%
Operating Margin 31.02%
Profit Margin 31.40%
FCF Margin -13.37%
ROA 23.91%
ROE 42.38%
ROIC 172.50%
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (3)

Buy 3
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

$35.33*
(148.28% upside)
Low
30.0
Current: $14.23
High
43.0
Target: 35.33
*Average 12-month price target from 3 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year20192018201720162015
Revenue0.210.040.01-0.01
Revenue Growth438.63%420.9%---
Gross Profit0.100.030.01-0.01
Operating Income-5.89-6.12-4.56-1.69-1.97
Net Income-6.20-6.27-6.96-1.93-2.04
Shares Outstanding16.7612.4810.969.889.36
Earnings Per Share-0.36-0.50-0.63-0.20-0.22
Operating Cash Flow-5.53-4.08-3.21-1.31-1.53
Capital Expenditures-0.11-0.04-0.13-0.01-0.12
Free Cash Flow-5.64-4.12-3.34-1.32-1.65
Cash & Equivalents0.890.953.531.000.03
Total Debt-1.91-3.391.01
Net Cash / Debt0.89-0.963.53-2.40-0.98
Assets2.221.554.661.300.37
Liabilities0.482.610.814.291.52
Book Value1.74-1.063.85-2.99-1.15
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Co-Diagnostics, Inc.
Country United States
Employees 39
CEO Dwight Howard Egan

Stock Information

Ticker Symbol CODX
Stock Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Unique Identifier NASDAQ: CODX
IPO Date July 12, 2017

Description

Co-Diagnostics, a molecular diagnostics company, intends to manufacture and sell reagents used for diagnostic tests that function via the detection and/or analysis of nucleic acid molecules. It also intends to sell diagnostic equipment from other manufacturers as self-contained lab systems. The company was founded in 2013 and is headquartered in Salt Lake City, Utah.